TKO Group sees 13‑fold insider buying edge as C‑suite stays quiet
Insider activity at TKO Group Holdings over the past twelve months shows a buy‑to‑sell value ratio of 13.06 ×, dwarfing typical market patterns. Coordinated purchases by four insiders in early June 2025 and three insiders in May 2026 add a layer of strategic timing that warrants close attention.
Over the last year TKO insiders have executed 11 purchases totaling $754.8 million against 94 sales worth $57.8 million, delivering a buy‑to‑sell ratio of 13.06 ×—well above the 2.0 × threshold that signals strong net buying. The bulk of the buying pressure originated from three 10 % owners who together placed three transactions worth $749.9 million, each acquiring 1,579,080 shares for roughly $250 million on June 3 2025. Their coordinated entry coincided with a secondary cluster that involved a fourth insider, pushing total inflows in the June 3‑5 window to $750.2 million. A second, smaller cluster emerged on May 13 2026 when three insiders collectively bought $4.5 million of stock within a single day.
The C‑suite has remained largely silent on the sell side. The CEO logged two purchases of $2.0 million, while the CFO’s activity was limited to two modest buys of $0.5 million and 24 sales totaling $5.7 million—well below the scale of the owner‑driven purchases. By contrast, directors have been active sellers, disposing of $46.1 million across 47 transactions, and an “Other Officer” has sold $6.0 million in 23 trades. The most sizable single sales were by Director Khan Nick, who off‑loaded 45,168 shares for $7.7 million on July 21 2025, and Director Shapiro Mark S, who sold 32,022 shares for $6.5 million on January 5 2026.
Monthly transaction patterns reinforce the concentration of buying in late 2024 and early 2025. December 2024 saw purchases of $878.8 million, January 2025 added $1.06 billion, February 2025 contributed $1.04 billion, and March 2025 recorded $3.6 million of buying activity. After this surge, the flow reversed, with sales dominating each subsequent month except for a modest buy‑back of $4.5 million in May 2026. The timing aligns with TKO’s current market metrics: the stock trades at $193.96, up 2.05 % on the day, with an RSI of 65 indicating modest upward momentum, yet the YTD return sits at –7.1 % and the price occupies roughly 56 % of its 52‑week range.
The disparity between owner‑level buying and director‑level selling suggests a divergence of conviction. Owners, who hold a direct economic stake, are committing capital at a scale that dwarfs routine compensation sales, while directors appear to be liquidating positions, possibly for diversification. The absence of CFO or CEO sales removes a common red flag associated with insider distress. Given the magnitude of the buy‑to‑sell ratio, the presence of two distinct cluster‑buy events, and the concentration of purchases among high‑ownership insiders, the insider data leans heavily toward a bullish interpretation, even as the broader market price remains modestly depressed.
Investors should monitor whether the owners sustain their buying cadence beyond the observed clusters and watch for any shift in C‑suite behavior, which would either reinforce or undermine the current insider‑driven signal.
Monthly Insider Activity
Activity by Role
Financial Details
| Buy Count | 11 |
| Sell Count | 94 |
| Buy Value | 754,815,951.50 |
| Sell Value | 57,804,224.28 |
| Total Value | 812,620,175.78 |
| Buy Sell Ratio | 13.06 |
| Cluster Buys | 2 |
| C Suite Activity | Yes |
Key Takeaways
- Buy‑to‑sell value ratio of 13.06 × over 12 months, far exceeding the 2.0 × bullish threshold.
- Three 10 % owners bought $749.9 million on June 3 2025, creating a coordinated cluster of four insiders in a 30‑day window.
- Directors sold $46.1 million across 47 transactions, while the CEO made only $2.0 million in purchases.
- Major buying spikes occurred in Dec 2024 ($878.8 M), Jan 2025 ($1.06 B) and Feb 2025 ($1.04 B); sales dominated thereafter.
- Current stock price $193.96, RSI 65, YTD return –7.1 %, positioning the stock near the mid‑point of its 52‑week range.